Chronic myeloid leukemia (CML) is a clonal myeloproliferative disease characterized by the presence of the BCR-ABL fusion gene, which results from the Philadelphia chromosome. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.